Honasa Consumer has received approval for the acquisition of Fluence Pharma, which offers condition-specific OTC supplement under the brand ‘Hair Fact, Skin Fact and Pro Fact’. The company will acquire majority 58% equity stake of Fluence Pharma via secondary purchase at Rs 135 crore enterprise value, subject to closing adjustments and completion of conditions precedent. The company will acquire remaining 42% equity stake of Fluence Pharma via secondary purchase in two tranches over the next 5-7 years from completion of acquisition of aforesaid stake.
This strategic acquisition marks Honasa's entry into the high-growth nutraceuticals space, reinforcing its commitment to building science-backed solutions that address evolving consumer needs across ‘inside-out’ beauty. Through this acquisition, Honasa Consumer will execute its entry into the category by establishing its dedicated subsidiary, Honasa Health. Under this new entity, the company will scale a highly differentiated B2C nutrition portfolio by combining Fluence’s patented clinical science and deep practitioner trust with its own expertise in brand building, consumer insights, and digital-first distribution. The board of directors of the company at its meeting held on June 23, 2026 approved the same.
Honasa Consumer, doing business as Mamaearth, provides e-commerce services. The company offers baby, skin, body, and hair care products, as well as mosquito protection roll on and creams.
| Company Name | CMP |
|---|---|
| Redington | 276.10 |
| Amrapali Industries | 32.28 |
| Adani Enterprises | 3036.10 |
| Rashi Peripheral | 772.40 |
| PDS | 364.15 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: